#mdpijcm
📢We are pleased to announce that JCM's 2025 Impact Factor has risen to 3.3, up from 2.9 — a 13.8% increase!
Our sincere gratitude to the Editorial Board, reviewers, and authors for your invaluable contributions🙌
#ImpactFactor2025#Q1Journal@MediPharma_MDPI
Pleased to share recent work from our research group reporting TGF-β1, pSmad-2/3, Smad-7, and β-Catenin signalling pathways in the pulmonary arteries from patients IPF and their potential role in driving EndMT.
Link to paper - https://t.co/cdnUiaIfsh
#mdpijcm
𝐉𝐂𝐌 𝐁𝐞𝐬𝐭 𝐏𝐡𝐃 𝐓𝐡𝐞𝐬𝐢𝐬 𝐀𝐰𝐚𝐫𝐝—Open for Applications
👉https://t.co/BDAyHn3C7R
Prize:
CHF 800;
A certificate;
A voucher to waive the Article Processing Charges (APCs) for one submission in the journal (subject to peer review)—valid for one year.
#mdpijcm
📢Call for Reading
#Issue_Cover Articles in 2025——For each issue, we have selected one article as the Issue Cover. In the first half of 2025, we have 12 articles we would like to share
🎯https://t.co/1xcOrUqVjU
@MediPharma_MDPI
Dietary supplementation w/ CoQ10 phytosome sign enhances physical performance in 👴👵 w/ statin-associated asthenia. This could have relevant implications for improving the compliance of older adults w/ statin treatment. Check it out on the Journal website https://t.co/accD0Fys3P
En pacientes con insuficiencia cardiaca, la embolia de pulmón aguda se asocia de forma independiente con un mayor riesgo de complicaciones precoces (muerte, sangrado, recurrencia) (HR 1.93; 95% CI 1.35–2.76). https://t.co/qzauQX74nC @JCM_MDPI@MDPIOpenAccess
🩺 Handheld echo = game changer for CHF care! New study shows non-cardiologists can deliver expert-level assessments at bedside.
Watch: https://t.co/3plydfz7fk
@JCM_MDPI#POCUS#CardioTwitter
Viewed by 13821👏👏👏
Check the 8 publications on #Aneurysm from the Special Issue edited by @Prof. Dr. Natzi Sakalihasan, @Dr. Lucia Musumeci from the University Hospital of Liège.
🔗https://t.co/ggBc2m3glN
@JCM_MDPI#clinic#aneurysm#endovascular